未登录

X

Xianhe Xie

fujian medical university

H指数:18

被引数:874

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Upregulation of PRSS27 driven by super-enhancers attenuates oxidative stress and apoptosis via activating PI3K/AKT pathway in lung adenocarcinoma

由超级增强子驱动的PRSS27上调通过激活PI3K/AKT通路来减轻氧化应激和凋亡，在肺腺癌中发挥作用。

IF5.1

2025-08-130

PRE

Treatment patterns and outcomes in advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in China

中国晚期或转移性胃/胃食管交界处腺癌的治疗模式和结果

FUTURE ONCOLOGY

IF2.6

2025-03-010

OAAI

Cinobufotalin inhibits proliferation, migration and invasion in hepatocellular carcinoma by triggering NOX4/NLRP3/GSDMD-dependent pyroptosis

华蟾素通过触发NOX4/NLRP3/GSDMD依赖性焦亡抑制肝细胞癌的增殖，迁移和侵袭

FRONTIERS IN ONCOLOGY

IF3.3

2024-10-160

OAAI

A novel super-enhancer-related risk model for predicting prognosis and guiding personalized treatment in hepatocellular carcinoma

IF3.4

2024-09-020

OAAI

Prognostic Value and Immune Signatures of Anoikis-related Genes in Breast Cancer

JOURNAL OF IMMUNOTHERAPY

IF2.9

2024-06-121

PRE

Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma

IF10.1

2024-05-010

PRE

Vital Sign Monitoring for Cancer Patients Based on Dual-Path Sensor and Divided-Frequency-CNN Model

IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS

IF6.8

2024-05-011

PRE

The Clinicopathological Characteristics of POLE-mutated Colorectal Cancer and the Prognostic Value of POLE Status

CLINICAL ONCOLOGY

IF3

2023-09-010

PRE

A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer

一种新的超级增强子相关基因标签可预测乳腺癌的预后和免疫微环境

IF3.4

2023-08-184

OAAI

Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2022-12-010

PRE

Efficacy and Safety of Immune Checkpoint Inhibitors in Triple-negative Breast Cancer: A Study Based on 41 Cohorts Incorporating 6558 Participants

免疫检查点抑制剂在三阴性乳腺癌中的疗效和安全性: 基于6558名参与者的41个队列的研究

JOURNAL OF IMMUNOTHERAPY

IF2.9

2022-11-161

PRE

The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients

POLE突变/超突变子宫内膜癌的临床病理特征及POLE状态的预后价值: 基于12,120例患者49篇文献的meta分析

IF3.4

2022-11-1011

OAAI

Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2022-11-094

OAAI

Donafenib in locally advanced/metastatic, radioactive iodine-refractory, differentiated thyroid cancer: A randomized, double-blind, placebo-controlled, multi-center phase III clinical trial (DIRECTION)

ANNALS OF ONCOLOGY

IF65.4

2022-09-012

OAAI

Lack of Efficacy of Immune Checkpoint Inhibitors in Cancer Patients Older Than 75?

JOURNAL OF IMMUNOTHERAPY

IF2.9

2022-06-093

PRE

The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants

IF3.4

2022-03-0415

OAAI

Intermittent administration of tacrolimus enhances \nanti-tumor immunity in melanoma-bearing mice

IF2.9

2022-02-091

PRE

The impact of antibiotics on efficacy of immune checkpoint inhibitors in malignancies: A study based on 44 cohorts

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2021-03-0124

PREAI

Establishment of an immune microenvironment-based prognostic predictive model for gastric cancer

基于免疫微环境的胃癌预后预测模型的建立

IF5.1

2020-11-019

PREAI

Functional tumor specific CD8+T cells in spleen express a high level of PD-1

脾脏中功能性肿瘤特异性CD8 T细胞表达高水平的PD-1

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2020-03-018

PREAI